4//SEC Filing
Thompson David E. 4
Accession 0001209191-11-002113
CIK 0001316175other
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 8:50 PM ET
Size
13.3 KB
Accession
0001209191-11-002113
Insider Transaction Report
Form 4
Thompson David E.
Director
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2011-01-03−8,151→ 3,531 totalExercise: $1.34Exp: 2018-06-26→ Common Stock (8,151 underlying) - Exercise/Conversion
Stock Option (right to buy)
2011-01-03−3,407→ 2,434 totalExercise: $1.51Exp: 2019-02-18→ Common Stock (3,407 underlying) - Exercise/Conversion
Common Stock
2011-01-03$1.34/sh+8,151$10,922→ 8,151 total(indirect: By Trust) - Exercise/Conversion
Common Stock
2011-01-03$1.51/sh+3,407$5,145→ 11,558 total(indirect: By Trust)
Holdings
- 20,443
Common Stock
Footnotes (3)
- [F1]The Reporting Person currently holds these shares under his own name and plans to transfer them to the David E. Thompson Revocable Trust.
- [F2]This Stock Option, representing the right to purchase a total of 11,682 shares of common stock of the Issuer, became immediately exercisable with respect to 100% of the shares subject to this Stock Option on the June 26, 2008 vesting start date (the "Vesting Start Date"). However, all unvested shares underlying this Stock Option are subject to a right of repurchase held by the Issuer, which lapses according to the following vesting schedule: in equal monthly installments over a four-year period beginning from the Vesting Start Date. This Stock Option is completely vested on the fourth anniversary of the Vesting Start Date.
- [F3]This Stock Option, representing the right to purchase a total of 5,841 shares of common stock of the Issuer, became immediately exercisable with respect to 100% of the shares subject to this Stock Option on the August 13, 2008 vesting start date (the "Vesting Start Date"). However, all unvested shares underlying this Stock Option are subject to a right of repurchase held by the Issuer, which lapses according to the following vesting schedule: in equal monthly installments over a four-year period beginning from the Vesting Start Date. This Stock Option is completely vested on the fourth anniversary of the Vesting Start Date.
Documents
Issuer
Anthera Pharmaceuticals Inc
CIK 0001316175
Entity typeother
Related Parties
1- filerCIK 0001484500
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 8:50 PM ET
- Size
- 13.3 KB